1 |
Christine C, Viviane SP, Catherine M, Pascal S, "Antibacterial Peptides: A Review," Science against microbial pathogens: communicating current research and technological advances, A. Mendez-Vilas (Ed.), 926-937" (2011).
|
2 |
Matsuzaki K. Sugishita K. Fujii N, Miyajima K., "Molecular-basis for membrane selectivity of an antimicrobial peptide, magainin-2," Biochemistry 34, 3423.3429 (1995).
DOI
ScienceOn
|
3 |
Glukhov E, Stark M. Burrows LL, Deber CM, "Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes." J. Biol. Chem. 280, 33960-33967 (2005).
DOI
ScienceOn
|
4 |
Shai, Y. "Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by -helical antimicrobial and cell non-selective membrane-lytic peptides," Biochim. Biophys. Acta, 1462, 55-70 (1999).
DOI
ScienceOn
|
5 |
Maloy WL, Kari UP, "Structure-activity studies on magainins and other host-defense peptides," Biopolymers, 37, 105, 122 (1995).
DOI
ScienceOn
|
6 |
Gottler LM, Ramamoorthy A, "Structure, membrane orientation, mechanism, and function of pexiganan: A highly potent antimicrobial peptide designed from magainin," Biochim. Biophys. Acta 1788, 1680-1686 (2009).
DOI
ScienceOn
|
7 |
Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y, "Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes," Biochemistry, 15, 31(49), 12416-23 (1992).
DOI
ScienceOn
|
8 |
Steve J, Ludtke KH, William TH, Thad AH, Lin Y, Huey WH, "Membrane Pores Induced by Magainin," Biochemistry 35, 13723-13728 (1996).
DOI
ScienceOn
|
9 |
Ehrenstein G, Lecar H, "Electrically gated ionic channels in lipid bilayers," Q Rev Biophys, 10(1), 1-34 (1977).
DOI
ScienceOn
|
10 |
Yeaman MR, Yount NY, "Mechanisms of antimicrobial peptide action and resistance," Pharmacol. Rev. 55, 27-55 (2003).
DOI
ScienceOn
|
11 |
Zasloff M, "Antimicrobial peptides of multicellular organisms," Nature 415, 389-395 (2002).
DOI
ScienceOn
|
12 |
van't HW, Veerman EC. Helmerhorst EJ. Amerongen AV, "Antimicrobial peptides: properties and applicability," The Journal of Biological Chemistry, 382(4), 597-619, (2001).
|
13 |
Hancock RE, Lehrer R, "Cationic peptides: a new source of antibiotics," Trends in Biotechnology, 16(2), 82-88 (1998).
DOI
ScienceOn
|
14 |
Virtanen JA, Cheng KH, Somerharju P, "Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model." Proc. Natl. Acad. Sci. USA, 95, 4964-4969 (1998).
DOI
|
15 |
Kevin JH, Lee DK, and Ramamoorthy A, "MSI-78, an Analogue of the Magainin Antimicrobial Peptides, Disrupts Lipid Bilayer Structure via Positive Curvature Strain," Biophysical Journal, 84, 3052-3060 (2003).
DOI
ScienceOn
|
16 |
Lee DK, Brender JR, Sciacca MFM, Krishnamoorthy J, Yu CS, Ramamoorthy A, "Lipid Composition-Dependent Membrane Fragmentation and Pore-Forming Mechanisms of Membrane Disruption by Pexiganan (MSI-78)," Biochemistry, 52, 32543263 (2013).
DOI
ScienceOn
|
17 |
Morein S, Andersson A, Rilfors L, Lindblom G, "Wild-type Escherichia coli cells regulate the membrane lipid composition in a "window" between gel and non-lamellar structures," J Biol Chem, 271(12), 6801-6809 (1996).
DOI
|
18 |
Maloy WL, Kari UP, "Structure-activity studies on magainins and other host-defense peptides," Biopolymers, 37, 105-122 (1995).
DOI
ScienceOn
|
19 |
Kresten B, Jerzy D, Sara KH, Niels CN, Thomas V, "Mechanisms of Peptide-Induced Pore Formation in Lipid Bilayers Investigated by Oriented 31P Solid-State NMR Spectroscopy," PLOS ONE, 7(10), e47745 (2012).
DOI
|
20 |
Porcelli F, Verardi R, Shi L, Henzler-Wildman KA, Ramamoorthy A, Veglia G., "NMR Structure of the Cathelicidin-Derived Human Antimicrobial Peptide LL-37 in Dodecylphosphocholine Micelles," Biochemistry, 47(20), 5565-5572 (2008).
DOI
ScienceOn
|
21 |
Fitzroy JB, Helim AE, Victor G, Romanenko G, Rothblat H, Irena L, "Cholesterol Depletion Increases Membrane Stiffness of Aortic Endothelial Cells," Biophysical Journal 87, 3336-3343 (2004).
DOI
ScienceOn
|
22 |
Chen G, Chen Y, Yang N, Zhu X, Sun L, Li G, "Interaction between curcumin and mimetic biomembrane," Sci China Life Sci, 55(6), 527-32 (2012).
|
23 |
Cesar A, Murray BE, "Antibiotic-Resistant Bugs in the 21st Century - A Clinical Super-Challenge," New England Journal of Medicine, 360(5), 439-443 (2009).
DOI
ScienceOn
|
24 |
Trantas E, Panopoulos N, Ververidis F, "Metabolic engineering of the complete pathway leading to heterologous biosynthesis of various flavonoids and stilbenoids in Saccharomyces cerevisiae," Metab. Eng, 11(6), 355-66 (2009).
DOI
ScienceOn
|
25 |
Lipsky B A. Holroyd K. J, Zasloff M, "Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: A randomized, controlled, double-blinded, multicenter trial of pexiganan cream," Clin. Infect. Dis. 47, 1537, 1545 (2008).
DOI
ScienceOn
|
26 |
Vanessa D, Christin K, Lindsay K, Mariya M, Wilson S, Carsten S, Duane F, Grant Z, Calmels F, Debruyne R, Golding GB, Poinar HN, Wright GD, "Antibiotic resistance is ancient," Nature, 477 (7365), 457-461 (2011).
DOI
ScienceOn
|
27 |
Fjell CD. Hiss JA. Hancock REW, Schneider G, "Designing antimicrobial peptides: Form follows function," Nat. Rev. Drug Discovery 11, 3751 (2012).
|
28 |
Fjell CD. Hiss JA. Hancock REW, Schneider G, "Designing antimicrobial peptides: Form follows function.," Nat. Rev. Drug Discovery 11, 37-51 (2012).
|
29 |
Epand R M, Vogel HJ, "Diversity of antimicrobial peptides and their mechanisms of action," Biochim. Biophys. Acta 1462, 11-28, (1999).
DOI
ScienceOn
|
30 |
Hancock REW, Sahl HG, "Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies," Nat. Biotechnol. 24, 1551-1557 (2006).
DOI
ScienceOn
|